Pediatrix Medical Group Statistics
Total Valuation
MD has a market cap or net worth of $759.63 million. The enterprise value is $1.28 billion.
| Market Cap | 759.63M |
| Enterprise Value | 1.28B |
Important Dates
The next estimated earnings date is Tuesday, April 30, 2024, before market open.
| Earnings Date | Apr 30, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
MD has 84.12 million shares outstanding. The number of shares has decreased by -2.28% in one year.
| Shares Outstanding | 84.12M |
| Shares Change (YoY) | -2.28% |
| Shares Change (QoQ) | -1.96% |
| Owned by Insiders (%) | 1.38% |
| Owned by Institutions (%) | 103.03% |
| Float | 81.66M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 7.02 |
| PS Ratio | 0.38 |
| Forward PS | 0.36 |
| PB Ratio | 0.89 |
| P/FCF Ratio | 7.30 |
| PEG Ratio | 0.88 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 42.95, with an EV/FCF ratio of 12.34.
| EV / Earnings | n/a |
| EV / Sales | 0.64 |
| EV / EBITDA | 42.95 |
| EV / EBIT | n/a |
| EV / FCF | 12.34 |
Financial Position
The company has a current ratio of 1.24, with a Debt / Equity ratio of 0.83.
| Current Ratio | 1.24 |
| Quick Ratio | 1.16 |
| Debt / Equity | 0.83 |
| Debt / EBITDA | 23.48 |
| Debt / FCF | 6.75 |
| Interest Coverage | -0.15 |
Financial Efficiency
Return on equity (ROE) is -6.60%.
| Return on Equity (ROE) | -6.60% |
| Return on Assets (ROA) | -2.60% |
| Return on Capital (ROIC) | n/a |
| Revenue Per Employee | $365,989 |
| Profits Per Employee | -$11,084 |
| Employee Count | 5,450 |
| Asset Turnover | 0.87 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, MD has paid $12.05 million in taxes.
| Income Tax | 12.05M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -38.70% in the last 52 weeks. The beta is 1.58, so MD's price volatility has been higher than the market average.
| Beta (1Y) | 1.58 |
| 52-Week Price Change | -38.70% |
| 50-Day Moving Average | 9.18 |
| 200-Day Moving Average | 10.98 |
| Relative Strength Index (RSI) | 44.24 |
| Average Volume (30 Days) | 680,124 |
Short Selling Information
The latest short interest is 4.12 million, so 4.90% of the outstanding shares have been sold short.
| Short Interest | 4.12M |
| Short Previous Month | 3.22M |
| Short % of Shares Out | 4.90% |
| Short % of Float | 5.05% |
| Short Ratio (days to cover) | 5.43 |
Income Statement
In the last 12 months, MD had revenue of $1.99 billion and -$60.41 million in losses. Loss per share was -$0.73.
| Revenue | 1.99B |
| Gross Profit | 421.57M |
| Operating Income | 7.32M |
| Pretax Income | -48.36M |
| Net Income | -60.41M |
| EBITDA | 29.89M |
| EBIT | -6.28M |
| Loss Per Share | -$0.73 |
Balance Sheet
The company has $177.74 million in cash and $701.65 million in debt, giving a net cash position of -$523.91 million or -$6.23 per share.
| Cash & Cash Equivalents | 177.74M |
| Total Debt | 701.65M |
| Net Cash | -523.91M |
| Net Cash Per Share | -$6.23 |
| Equity / Book Value | 849.06M |
| Book Value Per Share | 10.09 |
| Working Capital | 94.51M |
Cash Flow
In the last 12 months, operating cash flow was $137.33 million and capital expenditures -$33.33 million, giving a free cash flow of $104.00 million.
| Operating Cash Flow | 137.33M |
| Capital Expenditures | -33.33M |
| Free Cash Flow | 104.00M |
| FCF Per Share | $1.27 |
Margins
Gross margin is 21.13%, with operating and profit margins of 0.37% and -3.03%.
| Gross Margin | 21.13% |
| Operating Margin | 0.37% |
| Pretax Margin | -2.42% |
| Profit Margin | -3.03% |
| EBITDA Margin | 1.50% |
| EBIT Margin | -0.32% |
| FCF Margin | 5.21% |
Dividends & Yields
MD does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 2.28% |
| Shareholder Yield | 2.28% |
| Earnings Yield | -7.95% |
| FCF Yield | 13.69% |
Analyst Forecast
The average price target for MD is $9.38, which is 3.88% higher than the current price. The consensus rating is "Hold".
| Price Target | $9.38 |
| Price Target Difference | 3.88% |
| Analyst Consensus | Hold |
| Analyst Count | 4 |
| Revenue Growth Forecast (5Y) | 5.16% |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on December 20, 2013. It was a forward split with a ratio of 2:1.
| Last Split Date | Dec 20, 2013 |
| Split Type | Forward |
| Split Ratio | 2:1 |
Scores
MD has an Altman Z-Score of 1.18 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.18 |
| Piotroski F-Score | 6 |